<p><h1>Drug-Eluting Balloon Market Analysis and Market Size: Global Industry Overview, Market Segmentation and Forecast (2024 to 2031)</h1></p><p><strong>Drug-Eluting Balloon Market Analysis and Latest Trends</strong></p>
<p><p>A Drug-Eluting Balloon (DEB) is a specialized medical device used in the treatment of vascular diseases, particularly in angioplasty procedures. These balloons are coated with therapeutic agents that are slowly released into the arterial tissue during inflation, effectively reducing restenosis rates compared to standard balloons. DEBs are increasingly favored for treating conditions such as coronary artery disease and peripheral artery disease, enhancing patient outcomes by delivering localized medication directly to the affected area.</p><p>The Drug-Eluting Balloon Market is expected to grow at a CAGR of 11.8% during the forecast period, driven by the rising prevalence of cardiovascular diseases, an aging population, and advancements in technology. The increasing adoption of minimally invasive procedures further stimulates market demand. Additionally, regulatory approvals of new DEB products and growing awareness among healthcare providers about the advantages of DEBs over traditional therapy are key factors contributing to market growth. </p><p>Emerging trends include the development of innovative drug formulations, improved balloon mechanisms, and the integration of imaging technologies for better procedural outcomes. Collaborations between manufacturers and healthcare providers are enhancing product distribution, ultimately leading to expanded market presence and increased accessibility for patients globally.</p></p>
<p><strong>Get a Sample PDF of the Report:&nbsp;</strong> <a href="https://www.reliableresearchreports.com/enquiry/request-sample/1695011?utm_campaign=83&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=17122024&utm_id=drug-eluting-balloon">https://www.reliableresearchreports.com/enquiry/request-sample/1695011</a></p>
<p>&nbsp;</p>
<p><strong>Drug-Eluting Balloon Major Market Players</strong></p>
<p><p>The Drug-Eluting Balloon (DEB) market is characterized by strong competition, featuring key players including Boston Scientific, Medtronic, Cook Medical, C.R. Bard, B. Braun, Eurocor GmbH, Blue Medical, Bayer, Aachen Resonance, and Acrostak. These companies are driving innovation and addressing the growing demand for minimally invasive procedures in the treatment of vascular diseases.</p><p>Boston Scientific is a prominent player recognized for its advanced DEB technologies. The company has experienced steady growth, driven by its strong product portfolio and strategic acquisitions, including the recent acquisition of a leading DEB technology. Its sales revenue for the last fiscal year is estimated at approximately $11.5 billion, reflecting robust market performance.</p><p>Medtronic holds a significant share in the DEB market, fueled by continuous innovations and strategic partnerships. The companyâ€™s commitment to expanding its cardiovascular portfolio has resulted in a projected market growth rate of approximately 5-7% annually. Medtronic's sales revenue stands around $30 billion, with a notable portion attributed to its vascular devices.</p><p>Cook Medical shows strong capabilities in the DEB segment, focusing on interventional cardiology treatments and critical limb ischemia. The company is poised for growth with emerging markets adoption and ongoing R&D efforts, targeting areas that promise expanded use of DEB technologies.</p><p>B. Braun and C.R. Bard also contribute to the competitive landscape, with B. Braun emphasizing its niche in the peripheral vascular market, while C.R. Bard (now part of BD) leverages its experience in vascular health solutions.</p><p>Overall, the DEB market is expected to witness significant growth, driven by aging populations, an increase in cardiovascular diseases, and technological advancements, creating opportunities for robust market expansion across various regions.</p></p>
<p>&nbsp;</p>
<p><strong>What Are The Key Opportunities For Drug-Eluting Balloon Manufacturers?</strong></p>
<p><p>The Drug-Eluting Balloon (DEB) market is witnessing robust growth, driven by increasing cardiovascular diseases and procedural advancements. In 2023, the market is projected to surpass USD 1.5 billion, with a CAGR of about 9% through 2030. Key factors include rising adoption in peripheral and coronary interventions, alongside enhanced efficacy and safety profiles compared to traditional balloons. Moreover, technological innovations, such as biodegradable polymers and novel drug formulations, are expected to further propel market expansion. Future outlook remains positive, supported by aging populations and growing awareness of minimally invasive therapies, ensuring DEBs play a pivotal role in interventional cardiology.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report:</strong> <a href="https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1695011?utm_campaign=83&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=17122024&utm_id=drug-eluting-balloon">https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1695011</a></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The Drug-Eluting Balloon Market Analysis by types is segmented into:</strong></p>
<p><ul><li>Type I</li><li>Type II</li></ul></p>
<p><p>The Drug-Eluting Balloon market is categorized into Type I and Type II segments. Type I includes balloons coated with drugs that are released during angioplasty, effectively treating narrowed arteries while minimizing restenosis. These are primarily used in cardiovascular applications. Type II encompasses balloons designed for various medical uses beyond cardiology, focusing on localized drug delivery to treat conditions like peripheral artery disease and malignancies. Both types aim to enhance therapeutic outcomes and patient safety through targeted drug administration.</p></p>
<p><strong>Purchase this Report:&nbsp;</strong><a href="https://www.reliableresearchreports.com/purchase/1695011?utm_campaign=83&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=17122024&utm_id=drug-eluting-balloon">https://www.reliableresearchreports.com/purchase/1695011</a></p>
<p>&nbsp;</p>
<p><strong>The Drug-Eluting Balloon Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>Treatment of In-stent Restenosis (ISR)</li><li>Treatment of Small Vessel Disease (SVD)</li><li>Treatment of Bifurcation Stenoses</li><li>Treatment of Primary Coronary Artery Disease</li></ul></p>
<p><p>The drug-eluting balloon market addresses various cardiovascular conditions by delivering therapeutic agents directly to the vessel wall during angioplasty. For in-stent restenosis (ISR), these balloons reduce the likelihood of tissue regrowth within previously treated stents. In small vessel disease (SVD), they enhance outcomes in narrower arteries. Bifurcation stenoses treatments improve results at critical branching points, while for primary coronary artery disease, they facilitate effective revascularization, minimizing the risk of restenosis and improving overall patient outcomes.</p></p>
<p><a href="https://www.reliableresearchreports.com/drug-eluting-balloon-r1695011?utm_campaign=83&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=17122024&utm_id=drug-eluting-balloon">&nbsp;https://www.reliableresearchreports.com/drug-eluting-balloon-r1695011</a></p>
<p><strong>In terms of Region, the Drug-Eluting Balloon Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p><p>The Drug-Eluting Balloon (DEB) market is witnessing substantial growth across various regions. North America and Europe are projected to dominate this market, capturing approximately 35% and 30% of the share, respectively, due to advanced healthcare infrastructure and rising cardiovascular diseases. The Asia-Pacific (APAC) region, driven by increasing healthcare expenditures, is expected to account for about 25% of the market. China, with its rapidly expanding healthcare sector, is anticipated to contribute significantly, holding around 20% of the market share.</p></p>
<p><strong>Purchase this Report: </strong><a href="https://www.reliableresearchreports.com/purchase/1695011?utm_campaign=83&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=17122024&utm_id=drug-eluting-balloon">https://www.reliableresearchreports.com/purchase/1695011</a></p>
<p>&nbsp;<strong>Get a Sample PDF of the Report:&nbsp;&nbsp;</strong><a href="https://www.reliableresearchreports.com/enquiry/request-sample/1695011?utm_campaign=83&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=17122024&utm_id=drug-eluting-balloon">https://www.reliableresearchreports.com/enquiry/request-sample/1695011</a></p>
<p><strong></strong></p>
<p><p><a href="https://www.linkedin.com/pulse/regulatory-insights-interchangeable-lenses-market-2024-2031-policies-iz0se?utm_campaign=83&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=17122024&utm_id=drug-eluting-balloon">Interchangeable Lenses Market</a></p><p><a href="https://github.com/mharielmesa/Market-Research-Report-List-5/blob/main/gastrostomy-tube-market.md?utm_campaign=83&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=17122024&utm_id=drug-eluting-balloon">Gastrostomy Tube Market</a></p><p><a href="https://www.linkedin.com/pulse/in-depth-table-butter-market-review-size-share-141cagr-4epfe?utm_campaign=83&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=17122024&utm_id=drug-eluting-balloon">Table Butter Market</a></p><p><a href="https://www.linkedin.com/pulse/industrial-automatic-doors-market-in-depth-report-size-56vje?utm_campaign=83&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=17122024&utm_id=drug-eluting-balloon">Industrial Automatic Doors Market</a></p><p><a href="https://github.com/dringals/Market-Research-Report-List-6/blob/main/electrocautery-enhanced-delivery-system-market.md?utm_campaign=83&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=17122024&utm_id=drug-eluting-balloon">Electrocautery Enhanced Delivery System Market</a></p></p>